LeadIQ logo
Learn more at LeadIQ.com
Immune-Onc Therapeutics

Immune-Onc Therapeutics Employee Directory

Biotechnology ResearchCalifornia, United States11-50 Employees

Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a private, clinical-stage oncology company dedicated to discovering and developing novel biotherapeutics targeting myeloid cell inhibitory receptors. Headquartered in Palo Alto, California, Immune-Onc has assembled a diverse team with deep expertise in drug development and proven track records of success at leading biotechnology companies.

Immune-Onc has a differentiated pipeline with a current focus on targeting the Leukocyte Immunoglobulin-Like Receptor subfamily B (LILRB). Immune-Onc’s focused platform approach has led to the development of several promising therapeutics across various stages of development. Those include IO-108, an antagonist antibody targeting LILRB2 (also known as ILT4), in Phase 1b/2 clinical development for solid tumors, and IO-202, a first-in-class antagonist antibody targeting LILRB4 (also known as ILT3), in Phase 1b clinical development for the treatment of acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), and solid tumors. Additional assets in Immune-Onc’s pipeline include IO-106 (first-in-class antagonist antibody targeting LAIR1), IO-312 (a novel bispecific antibody targeting LILRB4 and CD3), and undisclosed immunology and oncology programs. For more information, please visit www.immune-onc.com.

Find Immune-Onc Therapeutics employees' phone numbers or email addresses

Immune-Onc Therapeutics Global Highlights

Location
Employees

North America
39

Minus sign iconPlus sign icon
  • United States Of America
    38
  • Canada
    1

Asia
4

Minus sign iconPlus sign icon
  • China
    2
  • Pakistan
    1
  • India
    1

Immune-Onc Therapeutics's Leadership

Immune-Onc Therapeutics Employee Metrics

100%
50%
0%
2024
2023
  • Engineering
  • Operations
  • Program & Project Management
  • Research
  • Administrative
  • Other
  • Consultant

Contact profiles from Immune-Onc Therapeutics

Name
Title
Contact Info
Location
Last Update

Frequently Asked Questions

What is Immune-Onc Therapeutics known for?

Minus sign iconPlus sign icon
Immune-Onc Therapeutics was founded in 2016 operates in the Biotechnology Research industry. The company's main headquarters is located in 795 San Antonio Rd Palo Alto, California 94303 US; you can contact the main corporate office by phone at . Explore Immune-Onc Therapeutics's company overview page for more information.

What is Immune-Onc Therapeutics's most common email format?

Minus sign iconPlus sign icon
Immune-Onc Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Immune-Onc Therapeutics email formats with LeadIQ.

How many employees does Immune-Onc Therapeutics have currently?

Minus sign iconPlus sign icon
Immune-Onc Therapeutics has approximately 26 employees as of September 2024. These team members are located across 2 continents, including North AmericaAsia.

Who are Immune-Onc Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of September 2024, Immune-Onc Therapeutics's key employees include:

  • Chief Development Officer: H. X.
  • Vice President Clinical Development: W. H. L.
  • Vice President Clinical Development: Y. T.
  • Ceo And President: K. P.
  • President: A. O.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.